BRIEF-Can-Fite Signs $42.7 Mln Out-Licensing Deal With Ewopharma

Reuters · 03/16/2021 11:25
BRIEF-Can-Fite Signs $42.7 Mln Out-Licensing Deal With Ewopharma

- Can Fite Biopharma Ltd CANF.TA:

  • CAN-FITE SIGNS $42.7 MILLION OUT-LICENSING DEAL WITH EWOPHARMA

  • CAN FITE BIOPHARMA LTD - SWISS EWOPHARMA TO MARKET PICLIDENOSON AND NAMODENOSON IN CENTRAL EASTERN EUROPE

Source text for Eikon: ID:nBw6tqGyda

Further company coverage: CANF.TA


((Reuters.Briefs@thomsonreuters.com;))